Fig. 3: mir182 in pHGG IV GB cell lines.
From: Circulating miRNAs as potential liquid biomarkers for pediatric gliomas
a mir182 expression in SF188 and KNS42 cells (*p < 0.0005; **p < 0.00001); b scratch wound healing assay showing mir182 inhibition (*p < 0.05) decreased migration ability of SF188 cells. c Trans-well migration assay demonstrating mir182 inhibition decreased KNS42 cells’ migration ability (*p < 0.0005); d Trans-well Invasion assays revealing that mir182 inhibition decreased the invasiveness of SF188 and KNS42 cells (*p < 0.05; **p < 0.005).
